9+ hour, 44+ min ago  (379+ words) In Association with CRScube Clinical data management is entering a new phase as AI automates EDC build, shortens timelines, and enables data teams to focus on validation, governance, and proactive quality oversight. The newest generation of AI-driven tools is beginning…...

1+ mon, 1+ week ago  (831+ words) In Association with Ocado Pharmaceutical and healthcare fulfilment operations are under enormous pressure, with a need to navigate multiple supply chain challenges. For many organisations turning to automation to handle fulfilment, the instinctive focus is on the'hardware: the robots, conveyors,…...

1+ mon, 2+ week ago  (482+ words) Deepanshu Saini, Director of Program Management at IQVIA reflects on the interplay between safety and AI pharmacovigilance. These shifts are driving new approaches to drug safety submissions and advancing models grounded in AI-ready PV. The next generation of PV prioritises…...

1+ mon, 2+ week ago  (121+ words) The new solution is intended for pharmaceutical and medical device manufacturers, enabling them to train operators, guide execution, and verify critical tasks using advanced AI-technologies. Manufacturers can utilise AI to document expert knowledge, guide workers through standardised procedures, and verify…...

1+ mon, 3+ week ago  (295+ words) The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery. In a move away from its core focus on DNA sequencing technology, San Diego-based biotech Illumina has debuted a genetic dataset designed…...

1+ mon, 3+ week ago  (323+ words) A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel drug discovery improvements. Eli Lilly and NVIDIA will establish a new artificial intelligence (AI) co-innovation lab, as the…...

7+ mon, 1+ week ago  (710+ words) In 2025, Turbine took the first steps in opening its powerful cell simulation platform to the wider drug development community, and researchers working in the antibody-drug conjugate space are the first to benefit. In Association with Turbine Artificial intelligence and machine…...

8+ mon, 1+ week ago  (229+ words) In Association with Veradigm Drug discovery has traditionally been slow, time-consuming, expensive and prone to failure, but AI and machine learning are set to change all that. AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly…...